EZH2 Expression and Response to Neoadjuvant Endocrine Therapy in Estrogen Receptor Positive Invasive Breast Cancer

被引：0
|
作者：
Fineberg, Susan [1 ]
Gan, Yujun [1 ]
机构：
[1] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [1] EZH2 Expression and Response to Neoadjuvant Endocrine Therapy in Estrogen Receptor Positive Invasive Breast Cancer
    Fineberg, Susan
    Gan, Yujun
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 115 - 116
  • [2] EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor Response
    Gan, Yujun
    Lo, Yungtai
    Makower, Della
    Kleer, Celina
    Lu, Jinyu
    Fineberg, Susan
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (09) : 614 - 622
  • [3] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
    Yamamoto, Yutaka
    Goto-Yamaguchi, Lisa
    Takeno, Masako
    Yamamoto-Ibusuki, Mutsuko
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
  • [4] Tumor Response to Neoadjuvant Chemotherapy Compared to Neoadjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor Positive Stage 2 to 3 Breast Cancer
    Tammaro, Yolanda
    Moses, Gregory
    Eastman, Amy
    Peng, Yan
    Euhus, David
    Leitch, A. Marilyn
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 110 - 111
  • [5] Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
    Lisa Goto-Yamaguchi
    Mutsuko Yamamoto-Ibusuki
    Yutaka Yamamoto
    Yoshitaka Fujiki
    Mai Tomiguchi
    Aiko Sueta
    Takashi Takeshita
    Hirotaka Iwase
    Breast Cancer Research and Treatment, 2018, 172 : 353 - 362
  • [6] Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
    Goto-Yamaguchi, Lisa
    Yamamoto-Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Fujiki, Yoshitaka
    Tomiguchi, Mai
    Sueta, Aiko
    Takeshita, Takashi
    Iwase, Hirotaka
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (02) : 353 - 362
  • [7] A PROMISING ALTERNATIVE: NEOADJUVANT ENDOCRINE THERAPY IN ESTROGEN AND PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER
    Malik, H.
    Pham, C.
    Garcia, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 556 - 557
  • [8] EZH2 Protein Expression and Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Del Grossi Neusquen, Lucienne Pereira
    Filassi, Jose Roberto
    Fristachi, Carlos Elias
    Carvalho, Katia Candido
    Doria, Maira Teixeira
    Soares Junior, Jose Maria
    Morales Piato, Jose Roberto
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2016, 38 (06): : 280 - 286
  • [9] Assessment of Pathologic Tumor Response to Neoadjuvant Endocrine Therapy in Postmenopausal Women with Estrogen Receptor Positive Stage 2 or 3 Breast Cancer
    Tammaro, Y. R.
    Moses, G.
    Eastman, A.
    Peng, Y.
    Euhus, D.
    Leitch, A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S87 - S87
  • [10] Inflammatory response to neoadjuvant endocrine therapy in hormone receptor-positive breast cancer
    Oner, G.
    Van Berckelaer, C.
    Praet, M.
    Canturk, N. Z.
    Altintas, S.
    Tjalma, W.
    Berneman, Z.
    Peeters, M.
    Pauwels, P.
    van Dam, P. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 79 - 80
12345